My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sinopharm Grp CO Unsp/Adr (OP:SHTDY)

13.72 +0.03 (+0.22%)

Streaming Delayed Price Updated: 1:47 PM EST, Feb 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sinopharm Grp CO Unsp/Adr

Current Analysis: Sinopharm Group (SHTDY) ↗

August 14, 2024

Founded in 2003, Sinopharm (SHTDY) is the largest wholesaler and retailer of drugs and medical devices in China. Over the past year, Sinopharm share price fell about 7% from $13.61 to $12.67 as...

Via Talk Markets

Current Analysis: Sinopharm Group ↗

November 13, 2023

Sinopharm Group Co. Ltd. was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Over the past year, Sinopharm’s share price rose about 20% from $10.26 to $12.36 as of...

Via Talk Markets

Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca ↗

August 26, 2023

China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may...

Via Talk Markets

Daily Stock Analysis: Sinopharm Group ↗

July 20, 2023

Sinopharm Group Co. Ltd.'s main business is drug distribution in mainland China, which contributes about 75% of total revenue.

Via Talk Markets

Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It ↗

November 22, 2022

COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.

Via Benzinga

UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots ↗

April 14, 2021

Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ...

Via Benzinga

South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report ↗

April 12, 2021

According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) /...

Via Benzinga

Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC ↗

April 08, 2021

The British government and health experts in the country have come forward to defend the COVID-19 vaccine developed by AstraZeneca plc’s (NASDAQ: AZN) and...

Via Benzinga

Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots ↗

April 07, 2021

The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed as a “very rare side effect” of the...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.